Cisatracurium Besylate recalls

Cisatracurium Besylate products have been recalled 4 times, most recently on 24 Dec 2025. The recalling company is usually Somerset Therapeutics. The most common reason is foreign material.

Total recalls4since 2021
Last 12 months3reported
Class I125% of total
Ongoing3latest 24 Dec 2025

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 1 25%Class II 0 0%Class III 3 75%

Why cisatracurium besylate is recalled

Product types

By year

Ongoing cisatracurium besylate recalls

3 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIICisatracurium Besylate Injection USP, 10 mg/* (2mg/mL) recalledCisatracurium BesylateSomerset TherapeuticsForeign MaterialNationwide
DrugCLASS IIICisatracurium Besylate Injection USP, 200mg/*(10mg/mL) recalledCisatracurium BesylateSomerset TherapeuticsForeign MaterialNationwide
DrugCLASS IIICisatracurium Besylate Injection USP, 20 mg/*,(2 mg/mL) recalledCisatracurium BesylateSomerset TherapeuticsForeign MaterialNationwide

All cisatracurium besylate recalls, newest first

4 total

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.